Rob Conley, MD, JD, MPH is a Senior Research Manager with the Center for Medical Technology Policy (CMTP). Most of his work involves the Green Park Collaborative-USA, a multi-stakeholder forum that develops condition- and technology-specific study design recommendations to guide the generation of evidence needed to inform both clinical and payment decisions. He is also actively engaged in a number of projects relating to health policy and research infrastructure.
Prior to joining CMTP, Dr. Conley practiced law with Arnold & Porter in Washington, D.C., where he was a partner in the food and drug regulatory and product liability litigation practices. Before beginning his legal practice, he clerked for the Hon. J. Harvie Wilkinson III on the U.S. Court of Appeals for the Fourth Circuit and worked for the American Medical Association as its Medical Ethics and Health Policy Fellow.
Dr. Conley obtained his MPH from the Bloomberg Johns Hopkins School of Public Health, his JD from the University of Virginia School of Law, and his MD from the University of North Carolina School of Medicine. His research experience includes bench and clinical research as well as cost-effectiveness Markov modeling.
Eleanor M. Perfetto, PhD, MS, is the Senior Vice President of Strategic Initiatives. She is also a professor of pharmaceutical health services research at the University of Maryland School of Pharmacy in Baltimore, Maryland, and the assistant editor of the Journal of Managed Care and Specialty Pharmacy (JMCP). Perfetto has previously served in various public policy and research positions, including work as the Senior Director, Federal Government Relations for Pfizer Inc; Senior Director of Epidemiology and Biostatistics at The Weinberg Group; Director of Health Outcomes Assessment, Clinical Research and Development, for Wyeth-Ayerst Research; and Senior Pharmacoepidemiologist for the U.S. Public Health Service, Agency for Health Care Policy and Research, Center for Medical Effectiveness Research.
Ellen leads multiple projects aimed at effectively engaging patients, clinicians, and other stakeholders in the research process. She currently leads CMTP’s collaborations with the Cystic Fibrosis Foundation and with the PCORI-funded Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN). Before coming to CMTP, she was a Research Associate in the Johns Hopkins University Bloomberg School of Public Health, Department of Health Policy and Management, where she conducted social science research in the area of Genetics and Public Policy Studies. Ellen holds an M.A. in Psychology from Wake Forest University.
Nora is currently working on various qualitative research projects focused on stakeholder engagement in health policy and clinical management decision-making. Prior to her work with CMTP, Ms. Osowski spent six years at the Institute of Medicine of the National Academies where she contributed to numerous consensus reports for the Board on Population Health and Public Health Practice and the Board on Health Sciences Policy. She received her MPH from the George Washington University, and following graduation spent one year working as a fellow at the Office on Women’s Health of the US Department of Health and Human Services.
Rachael is actively involved in a number of projects aimed at promoting quality methodology and increased use of comparative effectiveness research for evidence-based medicine and health policy decision-making. She has worked with a multidisciplinary team to build a set of guiding principles with specific criteria to aid researchers in their path from the identification of the research question to the most appropriate study design and methods to best answer decision makers’ research question. Most recently, Ms. Moloney has been working with a broad range of stakeholders (patients, practicing physicians, healthcare system administrators, payers and policy makers) to identify and address major barriers, including cultural, regulatory, financial, operational, and others, to the transformation from delivery system to a learning system in which evidence from PCTs and other research can continuously be generated efficiently and at low cost. Another focus of her work involves eliciting views from patients and other stakeholders about the acceptability of alternate models for informed consent in low-risk, real-world comparative effectiveness research, identifying characteristics of studies for which different models are more or less acceptable. Rachael received a Master of Health Science (MHS) in Epidemiology from Johns Hopkins Bloomberg School of Public Health and a Bachelor of Arts in Biological Sciences from the University of Chicago.
Chris Kamphaus is the Controller at the Center for Medical Technology Policy. As Controller, Chris works closely with the COO, Stuart Spector, and Operations team, overseeing all aspects of accounting, financial reporting and budgeting.
Chris most recently worked for a Columbia-based Private Equity fund in their accounting services division, where he was charged with managing existing lower to middle market accounting clients, as well as developing new potential private equity fund investments.
Chris earned his Bachelor’s Degree in Economics and Business Administration, as well as a Masters in Accounting from Rhodes College in Memphis, TN, where he also was a four-year member of the Golf Team.
Ms. Simmons is the Marketing and Communications Manager at the Center for Medical Technology Policy. Ms. Simmons is Certified Meeting Professional and serves on the Professional Convention Management Association's (PCMA) Awards and Recognition National Committee, and is a member of the PCMA Chesapeake Chapter. Ms. Simmons manages all CMTP meetings and events, and is also in charge of communications and marketing efforts for the organization. Prior to joining CMTP Ms. Simmons worked as a Conference Services Manager for National Conference Services, and was the President of the Student Organization for Activity Planning while pursuing her Bachelors of Arts at Salisbury University.
Dr. Mazonson has over 25 years of experience developing successful health care software and service companies. He has extensive experience in health care reimbursement and health economics. Prior to co-founding ClearCost Health, he served as Vice President of McKesson Corporation. Dr. Mazonson came to McKesson from Mosaic Health Care, a company he co-founded with Chris Santas that performed medical reimbursement consulting and developed reimbursement software for physicians. Other previous positions include President of Technology Assessment Group (an international outcomes research consulting firm), Senior Vice President of the Lewin Group, and Senior Vice President of R2 Technology (a software imaging company). Along with his work at ClearCost Health, Peter continues to practice part-time as a general internist in San Jose, CA. He received his BA from Harvard University, his MD from Dartmouth Medical School, and his MBA from Stanford.
Mark Gibson is Director of the Center for Evidence-based Policy at the Oregon Health and Science University and a program officer for the Milbank Memorial Fund. In these roles he works extensively with state policy makers to identify and obtain the research evidence they need to inform their policy deliberations.
Mr. Gibson became directly involved in state health policy deliberations when he served as Chief of Staff to Oregon Senate President John Kitzhaber M.D from 1985-1993. In this role Gibson supervised the staff of the Senate, and advised the President on the full range of issues considered by the Senate. During this time, Gibson participated directly in the drafting and passage of the groundbreaking Oregon Health Plan.
From 1995 through January of 2003, he served as Policy Advisor for Health, Human Services, and Labor to Governor John Kitzhaber of Oregon. In this role he led Oregon’s numerous health initiatives from Workers’ Compensation Reform, to creation of the Oregon Children’s Health Insurance Program and to a reorganization and expansion of the Oregon Health Plan. Most recently, Gibson led the effort to enact the Practitioner Managed Prescription Drug Plan, Oregon’s answer to runaway drug costs in its Medicaid program. This approach uses systematic reviews of global drug effectiveness research to guide the creation of a preferred drug list that is both clinically sound and economical.
From 2000 – 2002 Gibson served as Co-chair of the Reforming States Group, a voluntary nonpartisan collaboration of senior health policy officials from both the legislative and executive branches of state government.
Pamela Wescott, MPP is the Director of Patient Perspectives for the Foundation for Informed Medical Decision Making, a non-profit organization with the mission to inform and amplify the patient’s voice in health care decisions. Since 1998, Pam has been responsible for managing patient perspective content development for over 30 decision aids created by the Foundation in partnership with Health Dialog, a provider of healthcare decision support. She conducts focus groups and individual interviews with patients and providers around the United States, and helps ensure that their insights inform different stages of program development. She has helped to create videos to promote shared decision making, including “Transforming the Patient Experience,” which received International Health and Medical Media recognition.
Pam’s role has included collaborations with the Harvard Center for Cancer Prevention on a “Community Voices” video that explored how differences in culture, race and ethnicity affect health, and the Sophie Davis School of Biomedical Education, NYC, on whether an Informed Health Consumer decision aid could be effective in an underserved, multiracial population. The latter project resulted in interviews with community-based primary care providers whose observations are being prepared for web viewing along with patients describing Shared Decision Making as they have experienced it.
Pam previously managed research initiatives for Harvard’s Kennedy School of Government and Radcliffe Public Policy Institute, and taught focus group methodology to Harvard undergraduates and Harvard Law students. Ms. Wescott has a BA from Wellesley College and a Master’s in Public Policy from the University of California at Berkeley.
When her father was dying at home, Pam wrote a memoir, “Serving Life,” for which she was a Finalist for the Bakeless Nonfiction Literary Publication Prize at the Breadloaf Writer’s Conference. She has since published “The Love that Shouted for Joy,” a memoir about marrying her partner Kathleen in 2004.
Director, Consumer Engagement and Community Outreach
Jennifer Sweeney is the Director of Consumer Engagement and Community Outreach at the National Partnership for Women & Families. In her role, Jennifer works with foundations, federal government leaders, health care providers, community-based organizations, consumers and others to develop and implement strategies for improving the quality, safety, efficiency, and patient- and family-centeredness of the health care delivery system. She has extensive experience with multi-stakeholder engagement and deliberative processes, and a deep knowledge of delivery system models and quality improvement strategies aimed at achieving a more patient-centered, high quality health care system.
Jennifer sits on the Center for Medical Technology’s Patient and Consumer Advisory Committee and the Joint Commission’s Patient and Family Advisory Board. She is also a frequent speaker on health care issues, with a particular focus on consumer stakeholder engagement strategies.
Prior to joining the National Partnership for Women and Families, Jennifer was the Director of Public Policy at Business and Professional Women/USA (BPW/USA). As the organization’s top policy advisor, Jennifer worked to advance BPW/USA’s agenda on Capitol Hill, throughout the executive branch, and in coalition with partners from the business, women’s, and civil rights communities.
Before joining Business and Professional Women/USA, Jennifer was a Senior State Lobbyist with the American College of Obstetricians and Gynecologists (ACOG) and a Senior Research Consultant with the Corporate Executive Board, where she conducted literature reviews and produced “best-practice” benchmarking reports on gender and diversity issues for Fortune 500 companies.
She holds a bachelor's degree from Union College in Schenectady, NY and a master's degree from George Washington University in Washington, D.C.
Sandra Puczynski, PhD is a Professor of Medicine and Director of Clinical Research Development at Southern Illinois University School of Medicine since July 2007. Dr. Puczynski is responsible for clinical research planning and development and oversees the clinical research support and regulatory functions for the School of Medicine. She provides direction and guidance for clinical research investigators and their research personnel. She has been actively involved in the development of the Southern Illinois Practice Research Organization (SIPRO), a collaborative practice-based research network with the Southern Illinois Healthcare Foundation, one of the largest Federally Qualified Health Centers (FQHCs) in the country. Her research interests include diabetes, behavioral and health outcomes studies.
Dr. Puczynski is a member of the Juvenile Diabetes Research Foundation International (JDRF) Board of Chancellors. She is recognized for her patient advocacy work and for the redesign of the JDRF research program. JDRF is a non-profit organization with a research funding portfolio that exceeds $160 million annually. She serves on a number of international and national research committees, including past membership on the NIDDK Advisory Council.
Donna R. Cryer is chief executive officer of CryerHealth, a healthcare consultancy based in Washington, DC, providing advocacy and alliance development expertise to top pharmaceutical, biotech, and diagnostic companies, as well as the largest patient and physician associations in the United States and abroad. She is dedicated to ensuring that the voices and views of patients and physicians are heard in healthcare decision making.
Mrs. Cryer’s clinical trial experience includes creating the multicultural recruitment program for Matthews Media Group, a clinical trial recruitment firm now part of the Omnicom Group. Her clinical trial and multicultural health clients include deCODE genetics of Iceland, Boehringer Ingelheim, the Association of Black Cardiologists, the National Medical Association/W. Monague Cobb Health Policy Institute, and the National Minority Quality Forum.
A liver transplant recipient, Mrs. Cryer has been named to a five year term as a Patient Representative to the U.S. Food and Drug Administration and elected as the 1st patient to be chair of the board of the American Liver Foundation. Mrs. Cryer serves as an advisor to the Institute for Patient-Centered Design and has spoken on the topic of E-patients at the National Institutes of Health, American Association for the Advancement of Science, American Academy of Nursing, World Health Innovation and Technology Conference, and Princeton Medical Center.
An alumna of Harvard and Georgetown Law, Mrs. Cryer has been featured on CNN, Fox News, CBS Evening News, and NBC News. She serves on the advisory committee for the Women’s Health Institute at Howard University, the board of the Mid-Atlantic Chapter of the Healthcare Businesswomen’s Association, and is a member of the Women Business Leaders of the U.S. Health Care Industry Foundation, the American Society of Association Executives, and the Virginia State Bar.
A business and civic leader at the state and national level for many years, Mr. Sadwin is Chairman of the CMTP Board and President of the Friends of the World Heart Federation, Geneva, Switzerland. He recently served as the President/CEO of the Landmark HealthCare Foundation. Mr. Sadwin has been a tireless advocate for the American Heart Association for more than 25 years, after being diagnosed with, and losing his father to heart disease. He has served in nearly every volunteer capacity for the AHA, culminating with the prestigious post of 2001-02 Chairman of the Board, the chief volunteer executive officer responsible for the administration of the association’s business affairs, public relations and development.
In 2006, he was awarded the American Heart Association’s highest honor, the Gold Heart, and the John H. Chafee Award for Leadership in Healthcare. He was recently honored by the Army National Guard for his service in their Decade of Health initiative.
Mr. Sadwin is committed to furthering the cause of illness prevention by putting a face to heart disease, as was demonstrated when he was the model for an interpretive sculpture called “A Fine Line Between Hope and Despair,” by the artist Christianne Corbat, whose work explores the relationship among art, medicine, and healing. In addition to his advocacy for the American Heart Association, Mr. Sadwin has also served as a member of the Public Advisory Board of the Joint Commission and commissioner of National Health Council’s Putting Patients First initiative. He is past chairman of the board of Landmark Medical Center and a former member of the Council of Public Representatives for the National Institutes of Health. He currently serves as a Governor of the Miriam Hospital Foundation, Providence, Rhode Island.
His business career began at the age of 21, when, as a college senior at the University of Rhode Island, he took over his family’s textile manufacturing business, Sadwin Curtain Manufacturing Company, Inc., after the untimely death of his father. He served as the company’s CEO for the next 30 years. He has also held management positions with CitiGroup, General Electric, and The Torbot Group.
Janelle King is the Executive and Project Assistant at the Center for Medical Technology Policy. She supports not only the Executive Team and Program staff, but also coordinates the Board of Directors meetings. Ms. King has over seven years of administrative coordination experience and a vast knowledge of managing administrative tasks. Prior to joining CMTP, Ms. King worked at the Johns Hopkins Medical Institution in the Second Opinion Pathology Consultation office and other departments within the Johns Hopkins University System as an administrative professional.
Jennifer is involved in a number of projects focused on increasing stakeholder engagement in comparative effectiveness research and the advancement of research focused on patient reported outcomes. She is currently supporting a variety of CMTP initiatives including the NIH Collaboratory, a PCORI-funded project examining uterine fibroid treatments, and two methods and data infrastructure related proposals. Ms. Al Naber graduated with dual degrees in psychology and sociology from UMBC and received a Master of Science in Counseling Psychology with a concentration in Research from Loyola University Maryland. She is currently pursuing a degree in Health Policy and a certificate in Public Health Informatics from the Johns Hopkins Bloomberg School of Public Health.
Donna A. Messner, PhD, is the Senior Vice President at the Center for Medical Technology Policy (CMTP) where she oversees programs for research and stakeholder engagement to reduce barriers to clinical evidence development that is patient-centered, stakeholder-informed, and relevant to real-world decision-making. This has included work on streamlining informed consent in pragmatic clinical trials, identifying policy options to accelerate evidence generation and patient access for potentially important medical technologies, and research on the trends affecting the future of expectations for comparative effectiveness research of drugs, among other issues.
Dr. Messner leads the Green Park Collaborative (GPC), which is a multi-stakeholder forum to develop condition- and technology-specific study design recommendations for the generation of evidence needed to inform both clinical and payment decisions. With GPC, she has spearheaded a number of major initiatives, including the development of methods recommendations for determining the optimal sequence of cancer therapies for patients with metastatic/advanced cancer. She also leads a program to engage major health plans and other stakeholders to establish a framework for covering next-generation sequencing (NGS) testing in clinical oncology – and do so concurrently with creating strategies to reduce uncertainties associated with clinical use of NGS. This effort builds on CMTP’s previously released guidance on methods for demonstrating clinical utility of molecular diagnostic tests in oncology.
Dr. Messner holds a PhD and MSc (with distinction) in Science and Technology Studies from the University of Edinburgh, UK, an MA from George Mason University, and an undergraduate degree in chemistry from Virginia Tech. She was previously a research fellow in the Penn Center for the Integration of Genetic Health Care Technologies in the University of Pennsylvania’s Division of Medical Genetics; the Gordon Cain Fellow in Technology, Policy, and Entrepreneurship at the Chemical Heritage Foundation in Philadelphia; a visiting doctoral scholar in the School of Policy, Georgia Institute of Technology; and a long-time chemical laboratory director and senior project scientist.
Penny Mohr, MA, is Senior Vice President for Programs at the Center for Medical Technology Policy, where she has overall responsibilities for program development, project management, and scientific leadership. Before joining CMTP, she was Director of the Division of Research on Health Plans and Drugs within the Office of Research, Development, and Information at the Centers for Medicare and Medicaid Services (CMS), also serving as a technical authority within the Agency on issues pertaining to the adoption, diffusion, and cost-effectiveness of health care technology in the Medicare program. She was a member of CMS’ Council for Technology and Innovation, charged with coordinating coverage, coding and payment processes for new medical technologies, as well as promoting the exchange of information on new technologies between CMS and other entities. She holds advisory board positions on the American Journal of Managed Care, and Tufts-New England Medical Centers’ Center for Value and Risk in Health Care, and serves on the governing board for the International Society for Pharmacoeconomics and Outcomes Research.
Before working at CMS, she was a Senior Research Director at Project HOPE’s Center for Health Affairs, and outcomes research manager at MedSTAT, where she pursued longstanding interests in medical technology policy and cost-effectiveness research. She has published widely on a variety of health services research topics. Ms. Mohr received a Master’s degree at the University of Sussex, England where she studied economics.
Chief Operating Officer, Metro DC/Chesapeake Market
Stuart Spector is the Chief Operating Officer for the Metro DC/Chesapeake Market of Willis Towers Watson, which represents over $200M and 700 employees. He is the former Chief Operating Officer for CMTP and held that position from 2012 - 2016. Prior to joining CMTP, Spector was the Senior Vice President for the National Council on Aging (NCOA) where he led Corporate Partnerships, Public Policy, Marketing & Communications, Technology Initiatives and a variety of Programs designed to assist older adults. As part of the senior management team for NCOA, Stuart was instrumental in helping more than 3M seniors identify over $11B in public and private benefits options and was the catalyst for enrolling more than 500,000 seniors in Medicare’s Low Income Subsidy Program.
Prior to joining NCOA, Spector served as vice president and general manager for Vertafore, a leading provider of specialized software and services for the insurance industry. Before that, he served as chief operating officer for Benelogic, LLC, a web-based benefits administration firm for employers and insurance companies. He also co-founded Innovative Outsourcing, an infrastructure company servicing Medicare and Medicaid health care organizations, eventually merging the company with Group Benefit Services and serving as chief marketing officer for both organizations. Spector was recognized as one of the Top 40 Under 40 Emerging Business Leaders in 2003 and he earned the distinction of Entrepreneur of the Year Finalist from Ernst & Young in 2000. He has a Masters in Business Administration from the University of Maryland
Sean Tunis, MD, MSc is the Founder, President, and Chief Executive Officer of the Center for Medical Technology Policy in Baltimore, Maryland. CMTP’s main objective is to improve the quality and relevance of clinical research by providing a neutral forum for collaboration among experts, stakeholders and decision makers. Dr. Tunis was a member of the Institute of Medicine Committee on Initial National Priorities for Comparative Effectiveness Research. He advises a wide range of domestic and international public and private health care organizations on issues of comparative effectiveness, evidence based medicine, clinical research, reimbursement and health technology policy.
Through September of 2005, Dr. Tunis was the Director of the Office of Clinical Standards and Quality and Chief Medical Officer at the Centers for Medicare and Medicaid Services (CMS). In this role, he had lead responsibility for clinical policy and quality for the Medicare and Medicaid programs, which provide health coverage to over 100 million US citizens. Dr. Tunis supervised the development of national coverage policies, quality standards for Medicare and Medicaid providers; quality measurement and public reporting initiatives, and the Quality Improvement Organization program. As Chief Medical Officer, Dr. Tunis served as the senior advisor to the CMS Administrator on clinical and scientific policy. He also co-chaired the CMS Council on Technology and Innovation
Dr. Tunis joined CMS in 2000 as the Director of the Coverage and Analysis Group. Before joining CMS, Dr. Tunis was a senior research scientist with the Technology Assessment Group, where his focus was on the design and implementation of prospective comparative effectiveness trials and clinical registries. Dr. Tunis also served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S. Senate Committee on Labor and Human Resources, where he participated in policy development regarding pharmaceutical and device regulation.
He received a B.S. degree in Biology and History of Science from the Cornell University School of Agriculture, and a medical degree and masters in Health Services Research from the Stanford University School of Medicine. Dr. Tunis did his residency training at UCLA and the University of Maryland in Emergency Medicine and Internal Medicine. He is board certified in Internal Medicine and holds adjunct faculty appointments at Johns Hopkins, Stanford and the University of California San Francisco Schools of Medicine.